152 related articles for article (PubMed ID: 37695458)
21. Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study.
Barclay NL; Català M; Jödicke AM; Prieto-Alhambra D; Newby D; Delmestri A; Man WY; Serrano ÀR; Moncusí MP;
Ther Adv Med Oncol; 2024; 16():17588359241253115. PubMed ID: 38832300
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020.
Trama A; Bernasconi A; Botta L; Di Cosimo S; Miceli R; Claps M; Badenchini F; Lillini R; Rubino M; Lasalvia P
Int J Cancer; 2022 Nov; 151(9):1502-1511. PubMed ID: 35704342
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal Cancer Stage at Diagnosis Before and During the COVID-19 Pandemic in Japan.
Kuzuu K; Misawa N; Ashikari K; Kessoku T; Kato S; Hosono K; Yoneda M; Nonaka T; Matsushima S; Komatsu T; Nakajima A; Higurashi T
JAMA Netw Open; 2021 Sep; 4(9):e2126334. PubMed ID: 34546368
[TBL] [Abstract][Full Text] [Related]
24. Cancer Evaluations During the COVID-19 Pandemic: An Observational Study Using National Veterans Affairs Data.
Meyer AND; Singh H; Zimolzak AJ; Wei L; Choi DT; Marinez AD; Murphy DR
Am J Prev Med; 2022 Dec; 63(6):1026-1030. PubMed ID: 36055880
[TBL] [Abstract][Full Text] [Related]
25. Impact of COVID-19 on the incidence of localized and metastatic prostate cancer among White and Black Veterans.
Lee KM; Bryant AK; Alba P; Anglin T; Robison B; Rose BS; Lynch JA
Cancer Med; 2023 Feb; 12(3):3727-3730. PubMed ID: 35984395
[TBL] [Abstract][Full Text] [Related]
26. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.
Maringe C; Spicer J; Morris M; Purushotham A; Nolte E; Sullivan R; Rachet B; Aggarwal A
Lancet Oncol; 2020 Aug; 21(8):1023-1034. PubMed ID: 32702310
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic: a retrospective cohort study.
Williams R; Jenkins DA; Ashcroft DM; Brown B; Campbell S; Carr MJ; Cheraghi-Sohi S; Kapur N; Thomas O; Webb RT; Peek N
Lancet Public Health; 2020 Oct; 5(10):e543-e550. PubMed ID: 32979305
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the impact of COVID-19 on cancer declarations in Quebec, Canada.
Ramanakumar AV; Annie B; Frederic L; Christine B; Cathy R; Jean L
Cancer Med; 2023 Mar; 12(5):6260-6269. PubMed ID: 36385491
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
[TBL] [Abstract][Full Text] [Related]
30. Impact of the COVID-19 pandemic on the management of colorectal cancer in Denmark.
Smith HG; Jensen KK; Jørgensen LN; Krarup PM
BJS Open; 2021 Nov; 5(6):. PubMed ID: 34755189
[TBL] [Abstract][Full Text] [Related]
31. Cancer incidence during the COVID-19 pandemic by region of residence in Manitoba, Canada: A cancer registry-based interrupted time series study.
Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Singh H; Thiessen M; Pitz M; Musto G; Galloway K; Lambert P
Cancer Med; 2023 Dec; 12(23):21465-21479. PubMed ID: 37974380
[TBL] [Abstract][Full Text] [Related]
32. Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic.
Issaka RB; Taylor P; Baxi A; Inadomi JM; Ramsey SD; Roth J
JAMA Netw Open; 2021 Apr; 4(4):e216454. PubMed ID: 33843997
[TBL] [Abstract][Full Text] [Related]
33. Cancer diagnosis in primary care after second pandemic year in Catalonia: a time-series analysis of primary care electronic health records covering about 5 million people.
Mora N; Guiriguet C; Cantenys R; Méndez-Boo L; Marzo-Castillejo M; Benítez M; Fina F; Fàbregas M; Hermosilla E; Mercadé A; Medina M; Coma E
Fam Pract; 2023 Feb; 40(1):183-187. PubMed ID: 35861148
[TBL] [Abstract][Full Text] [Related]
34. Site-specific patterns of early-stage cancer diagnosis during the COVID-19 pandemic.
Kinslow CJ; DeStephano DM; Neugut AI; Taparra K; Horowitz DP; Yu JB; Cheng SK
JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38521544
[TBL] [Abstract][Full Text] [Related]
35. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study.
Morris EJA; Goldacre R; Spata E; Mafham M; Finan PJ; Shelton J; Richards M; Spencer K; Emberson J; Hollings S; Curnow P; Gair D; Sebag-Montefiore D; Cunningham C; Rutter MD; Nicholson BD; Rashbass J; Landray M; Collins R; Casadei B; Baigent C
Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):199-208. PubMed ID: 33453763
[TBL] [Abstract][Full Text] [Related]
36. Effects of the Pandemic on the Care of Patients With Colorectal Cancer.
Reinacher-Schick A; Ebert MP; Piso P; Hüppe D; Schmitt J; Schildmann J
Dtsch Arztebl Int; 2023 Aug; 120(33-34):545-552. PubMed ID: 37427989
[TBL] [Abstract][Full Text] [Related]
37. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
[TBL] [Abstract][Full Text] [Related]
38. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
[TBL] [Abstract][Full Text] [Related]
39. The impact of COVID-19 on national program of colorectal cancer screening in Tehran, Iran: a multicenter study.
Sadeghi A; Asadzadeh Aghdaei H; Khalafi MA; Nazemalhosseini-Mojarad E; Ketabi Moghadam P; Sohrabi MR
BMC Cancer; 2023 Jul; 23(1):627. PubMed ID: 37407931
[TBL] [Abstract][Full Text] [Related]
40. Impact of the COVID-19 pandemic and related control measures on cancer diagnosis in Catalonia: a time-series analysis of primary care electronic health records covering about five million people.
Coma E; Guiriguet C; Mora N; Marzo-Castillejo M; Benítez M; Méndez-Boo L; Fina F; Fàbregas M; Mercadé A; Medina M
BMJ Open; 2021 May; 11(5):e047567. PubMed ID: 34006554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
